Noah Weisleder received his B.S. in Biotechnology from Worcester Polytechnic Institute and a Ph.D. in Cell Biology from Baylor College of Medicine. He conducted his postdoctoral studies at Robert Wood Johnson Medical School where he joined the faculty as Assistant Professor in the Department of Physiology and Biophysics. Currently, Dr. Weisleder is Professor and Director of Graduate Studies in the Department of Physiology and Cell Biology at The Ohio State University Wexner Medical Center. He also serves as the Director of the Office of Postdoctoral Affairs at The Ohio State University.
Dr. Weisleder has published numerous peer-reviewed publications or book chapters in the fields of muscle physiology, cardiovascular disease, cytoskeletal dynamics, membrane repair, and cellular calcium homeostasis in normal physiology and disease states. His research in these areas has been supported by the NIH and several private foundations, including the Muscular Dystrophy Association, Children’s Cardiomyopathy Foundation, and the National Football League.
He has chaired sessions at national and international meetings on muscle physiology and metabolism and currently serves on the scientific advisory panels of the MDA and American Federation for Aging Research. Additionally, he is an inventor on dozens of US and international patents. These inventions became the basis for the formation of TRIM-edicine, a biotechnology company developing protein therapeutics targeting regenerative medicine applications, where Dr. Weisleder is a Founder and previously served as Chief Scientific Officer. He has received a Fellowship from the American Heart Association, a Pathway to Independence Award from the National Institutes of Health, and the Kauffman Foundation Outstanding Postdoctoral Entrepreneur Award.